Literature DB >> 12955189

NF-kappaB in critical diseases: a bad guy?

Uwe Senftleben.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12955189     DOI： 10.1007/s00134-003-1932-7

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN： 0342-4642            Impact factor:   17.440


× No keyword cloud information.
  30 in total

Review 1.  The role of nuclear factor-kappa B in pulmonary diseases.

Authors:  J W Christman; R T Sadikot; T S Blackwell
Journal:  Chest       Date:  2000-05       Impact factor: 9.410

2.  Increased nuclear factor kappa B activation in critically ill patients who die.

Authors:  R L Paterson; H F Galley; J K Dhillon; N R Webster
Journal:  Crit Care Med       Date:  2000-04       Impact factor: 7.598

3.  Possible new role for NF-kappaB in the resolution of inflammation.

Authors:  T Lawrence; D W Gilroy; P R Colville-Nash; D A Willoughby
Journal:  Nat Med       Date:  2001-12       Impact factor: 53.440

4.  Severe liver degeneration in mice lacking the IkappaB kinase 2 gene.

Authors:  Q Li; D Van Antwerp; F Mercurio; K F Lee; I M Verma
Journal:  Science       Date:  1999-04-09       Impact factor: 47.728

5.  TGF-beta-induced p38 activation is mediated by Rac1-regulated generation of reactive oxygen species in cultured human keratinocytes.

Authors:  C Chiu; D A Maddock; Q Zhang; K P Souza; A R Townsend; Y Wan
Journal:  Int J Mol Med       Date:  2001-09       Impact factor: 4.101

6.  A novel X-linked disorder of immune deficiency and hypohidrotic ectodermal dysplasia is allelic to incontinentia pigmenti and due to mutations in IKK-gamma (NEMO).

Authors:  J Zonana; M E Elder; L C Schneider; S J Orlow; C Moss; M Golabi; S K Shapira; P A Farndon; D W Wara; S A Emmal; B M Ferguson
Journal:  Am J Hum Genet       Date:  2000-10-24       Impact factor: 11.025

7.  The phosphorylation status of nuclear NF-kappa B determines its association with CBP/p300 or HDAC-1.

Authors:  Haihong Zhong; Michael J May; Eijiro Jimi; Sankar Ghosh
Journal:  Mol Cell       Date:  2002-03       Impact factor: 17.970

8.  The two faces of IKK and NF-kappaB inhibition: prevention of systemic inflammation but increased local injury following intestinal ischemia-reperfusion.

Authors:  Lee-Wei Chen; Laurence Egan; Zhi-Wei Li; Florian R Greten; Martin F Kagnoff; Michael Karin
Journal:  Nat Med       Date:  2003-04-07       Impact factor: 53.440

Review 9.  Cellular response to oxidative stress: signaling for suicide and survival.

Authors:  Jennifer L Martindale; Nikki J Holbrook
Journal:  J Cell Physiol       Date:  2002-07       Impact factor: 6.384

10.  Genomic rearrangement in NEMO impairs NF-kappaB activation and is a cause of incontinentia pigmenti. The International Incontinentia Pigmenti (IP) Consortium.

Authors:  A Smahi; G Courtois; P Vabres; S Yamaoka; S Heuertz; A Munnich; A Israël; N S Heiss; S M Klauck; P Kioschis; S Wiemann; A Poustka; T Esposito; T Bardaro; F Gianfrancesco; A Ciccodicola; M D'Urso; H Woffendin; T Jakins; D Donnai; H Stewart; S J Kenwrick; S Aradhya; T Yamagata; M Levy; R A Lewis; D L Nelson
Journal:  Nature       Date:  2000-05-25       Impact factor: 49.962
View more
  7 in total

Review 1.  Year in review in intensive care medicine-2003. Part 3: intensive care unit organization, scoring, quality of life, ethics, neonatal and pediatrics, and experimental.

Authors:  Edward Abraham; Peter Andrews; Massimo Antonelli; Laurent Brochard; Christian Brun-Buisson; Geoffrey Dobb; Jean-Yves Fagon; Johan Groeneveld; Jordi Mancebo; Philipp Metnitz; Stefano Nava; Michael Pinsky; Peter Radermacher; Marco Ranieri; Christian Richard; Robert Tasker; Benoit Vallet
Journal:  Intensive Care Med       Date:  2004-06-26       Impact factor: 17.440

2.  Blockade of nuclear factor-kappaB activation prevents hypodynamic shock and gastric hypoperfusion induced by endotoxin in anesthetized dogs.

Authors:  Chieko Mitaka; Yukio Hirata; Yutaka Narumi; Kuninori Yokoyama; Koshi Makita; Koichi Katsuyama; Takasuke Imai
Journal:  Intensive Care Med       Date:  2005-04-06       Impact factor: 17.440

3.  Protective effect of isoliquiritigenin against cerebral injury in septic mice via attenuation of NF-κB.

Authors:  Peng Zou; Hong-Ming Ji; Jian-Wei Zhao; Xin-Min Ding; Zi-Gang Zhen; Xuan Zhang; Xiao-Qi Nie; Li-Xiong Xue
Journal:  Inflammopharmacology       Date:  2018-06-26       Impact factor: 4.473

4.  Effects of 15-deoxy-Delta12,14-prostaglandin-J2 during hyperdynamic porcine endotoxemia.

Authors:  Balázs Hauser; Jochen Kick; Zsolt Iványi; Pierre Asfar; Ulrich Ehrmann; Claus-Martin Muth; Maura Albicini; Ulrich Wachter; Josef Vogt; Michael Bauer; Uwe Bernd Brückner; Peter Radermacher; Hendrik Bracht
Journal:  Intensive Care Med       Date:  2006-03-14       Impact factor: 17.440

5.  Determination of free and protein-bound glutathione in HepG2 cells using capillary electrophoresis with laser-induced fluorescence detection.

Authors:  Yan Wang; Yi Xie; Michel Bernier; Irving W Wainer
Journal:  J Chromatogr A       Date:  2008-06-22       Impact factor: 4.759

6.  Propofol attenuates LPS-induced tumor necrosis factor-α, interleukin-6 and nitric oxide expression in canine peripheral blood mononuclear cells possibly through down-regulation of nuclear factor (NF)-κB activation.

Authors:  Zengyang Pei; Jinqiu Wang
Journal:  J Vet Med Sci       Date:  2014-10-14       Impact factor: 1.267

7.  In silico simulation of corticosteroids effect on an NFkB- dependent physicochemical model of systemic inflammation.

Authors:  Panagiota T Foteinou; Steve E Calvano; Stephen F Lowry; Ioannis P Androulakis
Journal:  PLoS One       Date:  2009-03-10       Impact factor: 3.240
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.